Details for Patent: 9,868,103
✉ Email this page to a colleague
Which drugs does patent 9,868,103 protect, and when does it expire?
Patent 9,868,103 protects EPSOLAY and TWYNEO and is included in two NDAs.
This patent has sixteen patent family members in eleven countries.
Summary for Patent: 9,868,103
| Title: | Metal oxide coating of water insoluble ingredients |
| Abstract: | The invention relates to process for coating a solid, water-insoluble particulate matter, with a metal oxide comprising: (a) contacting the solid water-insoluble particulate matter with a cationic additive in an aqueous medium to obtain a dispersion of said particulate matter having a positive zeta potential; (b) coating the solid water-insoluble particulate matter by precipitation of a metal oxide salt onto the surface of the particulate matter, forming a metal oxide layer thereon; and (c) aging said coating layer. The invention further relates to coated particulate matter obtained by the process and to compositions comprising solid, water-insoluble particulate matter, coated by a metal oxide layer, the particulate matter being a dermatological active agent or a pesticide. The invention additionally relates to methods of treating a surface condition in a subject using compositions comprising solid, water insoluble dermatologically active agent, coated by a metal oxide layer. |
| Inventor(s): | Toledano; Ofer (Kfar Saba, IL), Sertchook; Hanan (Gedera, IL), Loboda; Natalia (Jerusalem, IL), Bar-Simantov; Haim (Modiin, IL) |
| Assignee: | SOL-GEL TECHNOLOGIES LTD. (Ness Ziona, IL) |
| Application Number: | 11/997,823 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; Process; Dosage form; |
Drugs Protected by US Patent 9,868,103
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | EPSOLAY | benzoyl peroxide | CREAM;TOPICAL | 214510-001 | Apr 22, 2022 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TOPICAL TREATMENT OF INFLAMMATORY LESIONS OF ROSACEA IN ADULTS 18 YEARS OF AGE AND OLDER | ⤷ Sign Up | |||
| Galderma Labs Lp | TWYNEO | benzoyl peroxide; tretinoin | CREAM;TOPICAL | 214902-001 | Jul 26, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TOPICAL TREATMENT OF ACNE VULGARIS IN ADULTS AND PEDIATRIC PATIENTS 9 YEARS OF AGE AND OLDER | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,868,103
| PCT Information | |||
| PCT Filed | August 02, 2006 | PCT Application Number: | PCT/IL2006/000892 |
| PCT Publication Date: | February 08, 2007 | PCT Publication Number: | WO2007/015243 |
International Family Members for US Patent 9,868,103
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006274541 | ⤷ Sign Up | |||
| Brazil | PI0614143 | ⤷ Sign Up | |||
| Canada | 2617681 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
